Bioresorbable scaffolds: clinical results

Presentations available when logged in:

  • Implantation of ABSORB everolimus-eluting bioresorbable vascular scaffolds in the setting of ACS patients
  • Absorb extend: an interim report on the 12-month clinical outcomes of approximately 400 patients enrolled
  • 2-year clinical data and multimodality imaging results up to 1-year follow-up of the BIOSOLVE-I study with the paclitaxel-eluting bioabsorbable mag...
  • Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffo...